zk1516564.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
SCHEDULE 14A
 
(Rule 14a-101)
SCHEDULE 14A INFORMATION
 
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.      )
 
Filed by the Registrant x
 
Filed by a Party other than the Registrant o
 
Check the appropriate box:
 
o
Preliminary Proxy Statement.
 
o
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)).
 
o
Definitive Proxy Statement.
 
x
Definitive Additional Materials.
 
o
Soliciting Material Pursuant to §240.14a-12.
 
Pluristem Therapeutics Inc.
(Name of Registrant as Specified In Its Charter)  
 
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
     
Payment of Filing Fee (Check the appropriate box):
     
x
No fee required.
     
o
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
     
 
(1) 
Title of each class of securities to which transaction applies:
     
 
(2)
Aggregate number of securities to which transaction applies:
     
 
(3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
     
 
(4)
Proposed maximum aggregate value of transaction:
     
 
(5)
Total fee paid:
 
 
 
 
     
o
Fee paid previously with preliminary materials.
     
o
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
     
 
(1)
Amount Previously Paid:
     
 
(2)
Form, Schedule or Registration Statement No.:
     
 
(3)
Filing Party:
     
 
(4)
Date Filed:

 
 
 
 
 *** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on May 26, 2015.
 
           PLURISTEM THERAPEUTICS, INC.   Meeting Information
   
 
Meeting Type:                    Annual Meeting
    For holders as of:              April 1, 2015
Date:   May 26, 2015                      Time:   5:00 PM Local Time 
Location:        Matam Advanced Technology Park
                        Building No. 5
                         Haifa, 31905
                         Israel
     
    You are receiving this communication because you hold shares in the company named above.
     
PLURISTEM THERAPEUTICS, INC.
MATAM ADVANCED TECHNOLOGY PARK
BUILDING NO. 5
HAIFA L3 31905 ISRAEL
   This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). You may also review materials at http://www.pluristem.com/index.php/investors/shareholders-annual-meeting-2015.html.
     
    We encourage you to access and review all of the important information contained in the proxy materials before voting.
     
   
See the reverse side of this notice to obtain
proxy materials and voting instructions.
  
 
 
 
—  Before You Vote  —
How to Access the Proxy Materials
 
Proxy Materials Available to VIEW or RECEIVE:
THE PROXY STATEMENT           ANNUAL REPORT
 
How to View Online:
Have the information that is printed in the box marked by the arrow g (located on the following page) and visit: www.proxyvote.com or visit http://www.pluristem.com/index.php/investors/shareholders-annual-meeting-2015.html.
 
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. You will not otherwise receive a paper or email copy. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
 
                                                         1) BY INTERNET:                www.proxyvote.com
                                                         2) BY TELEPHONE:            1-800-579-1639
                                                         3) BY E-MAIL*:                    sendmaterial@proxyvote.com
 
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow g(located on the following page) in the subject line.
 
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 8, 2015 to facilitate timely delivery.
 
 
—  How To Vote  —
Please Choose One of the Following Voting Methods
 
Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. For directions to the annual meeting please call 972-74-7108600.
 
Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Use the Internet to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have the information that is printed in the boxmarked by the arrow g (located on the following page) available and follow the instructions.
 
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
 
 
 
 
 
Voting Items        
 
The Board of Directors recommends you vote FOR the following:   The Board of Directors recommends you vote FOR proposals 2 and 3.
         
1. To elect the following nominees to the board of directors to serve as directors of the Company until the next annual meeting of the stockholders and until his or her successor iselected and qualified or his or her earlier resignation or removal.   2.
To consider and approve, by a nonbinding advisory vote, the compensation of the Company's named executive officers.
  Nominees:   3. To ratify the selection of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2015.
         
 
01)     Zami Aberman
 
   NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
  02)     Israel Ben-Yoram      
         
  03)     Isaac Braun      
         
  04)     Mark Germain      
         
  05)     Moria Kwiat      
         
  06)     Hava Meretzki      
         
  07)     Nachum Rosman      
         
  08)     Doron Shorrer      
         
  09)     Yaky Yanay